Top Stories
-
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
Topic
-
In the past decade, physicians have recommended that women undergoing some surgeries have their fallopian tubes removed at the same time to prevent ovarian cancer.
Topic
-
Columbia expert Dr. Fatemeh Momen-Heravi shares facts about HPV-related cancer risk factors and prevention.
Topic
-
A significantly lower proportion of Hispanic and Black women who underwent screening received 3D mammograms, according to a new study presented at the 2022 San Antonio Breast Cancer Symposium.
Topic
Latest News
- March 17, 2022
In the future, bacteria may be let loose in the body to seek and destroy cancer cells, but the bacteria need a way to hide from our immune system. Columbia biomedical engineers may have a solution.
- March 17, 2022
In the early days of Columbia's cancer program, several incredible women physicians and scientists made key discoveries in the field.
- March 7, 2022
Having a rapport with kids is a critical part of the job for James Church and other Columbia colorectal surgeons who treat people with hereditary colon cancer.
Topic
- March 3, 2022
Lung cancer often spreads to the brain. Columbia scientists have now uncovered a tactic used by metastases to hide in the brain and identified a drug combination that can potentially target them.
Topic
- February 22, 2022
By applying artificial intelligence to standard-of-care imaging, Columbia cancer researchers can predict how well immunotherapy will work for patients with melanoma.
Topic
- February 4, 2022
A clinical trial led by a Columbia neuro-oncology team suggests that a new type of anti-cancer drug has promise for patients with glioblastoma.
- January 27, 2022
Active surveillance has emerged as a safe option for some thyroid cancers, illustrating that less can be more in thyroid cancer management.
- January 25, 2022
Columbia cancer researchers are developing virtual reality technology to visualize and explore cancer tumors and gain new insights.
- January 24, 2022
Barbara Pro, MD, a leader in lymphoma research and care, has been named clinical director of the lymphoma program at Columbia University's Herbert Irving Comprehensive Cancer Center.
- January 19, 2022
New Columbia research suggests that targeting neighboring bone cells may be a better strategy than targeting malignant stem cells to treat acute myeloid leukemia.
Topic
